Suzhou Basecare Medical Corporation Limited (2170.HK)
HKD 2.75
(-8.94%)
HKD 2.75
(-8.94%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 207.97 Million | 140.9 Million | 107.29 Million | 81.1 Million | 55.68 Million | 32.6 Million |
| Cost of Revenue | 116.62 Million | 81.37 Million | 56.15 Million | 53.39 Million | 29.43 Million | 24.47 Million |
| Gross Profit | 91.35 Million | 59.52 Million | 51.14 Million | 27.71 Million | 26.25 Million | 8.13 Million |
| Operating Expenses | 285.06 Million | 277.8 Million | 196.27 Million | 82.47 Million | 36.51 Million | 61.04 Million |
| Selling, General and Administrative Expenses | 209.3 Million | 161.49 Million | 114.63 Million | 41.86 Million | 13.56 Million | 13.74 Million |
| Research and Development Expenses | 129.56 Million | 119.77 Million | 73.71 Million | 34.48 Million | 19.88 Million | 18.81 Million |
| Other Expenses | -53.8 Million | 2.23 Million | 2.43 Million | 668 Thousand | 591 Thousand | 878 Thousand |
| Cost and Expenses | 401.68 Million | 359.17 Million | 252.42 Million | 135.86 Million | 65.94 Million | 85.51 Million |
| Operating Income | -193.7 Million | -126.11 Million | -124.48 Million | -53.46 Million | -8.73 Million | -51.81 Million |
| Interest Expense | 2.61 Million | 3.1 Million | 1.26 Million | 1.47 Million | 1.31 Million | 927 Thousand |
| Income Tax Expense | -2.97 Million | 6.01 Million | 18.33 Million | -7.39 Million | -2.29 Million | -5.06 Million |
| Earnings before Tax | -196.31 Million | -126.61 Million | -125.74 Million | -881.51 Million | -530.57 Million | -157 Million |
| Net Income | -191.68 Million | -123.16 Million | -143.65 Million | -877.05 Million | -531.33 Million | -154.87 Million |
| Earnings Per Share Basic | -0.70 | -0.45 | -0.54 | -3.29 | -1.99 | -0.58 |
| Earnings Per Share Diluted | -0.70 | -0.45 | -0.54 | -3.29 | -1.99 | -0.58 |
| Weighted Average Shares Outstanding | 273.52 Million | 273.52 Million | 265.32 Million | 266.66 Million | 266.66 Million | 266.66 Million |
| Weighted Average Shares Outstanding (Diluted) | 273.52 Million | 273.52 Million | 265.32 Million | 266.66 Million | 266.66 Million | 266.66 Million |
| Gross Margin | 0.44 | 0.42 | 0.48 | 0.34 | 0.47 | 0.25 |
| EBIT Margin | -0.84 | -0.84 | -1.11 | -0.57 | -0.02 | -1.35 |
| Profit Margin | -0.92 | -0.87 | -1.34 | -10.81 | -9.54 | -4.75 |
| EBITDA | -174.14 Million | -117.73 Million | -118.88 Million | -873.32 Million | -520.88 Million | -148.01 Million |
| Earnings Before Tax Margin | -0.93 | -0.90 | -1.16 | -0.66 | -0.16 | -1.59 |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 207.97 Million | 132.26 Million | 96.74 Million | 140.9 Million | 81.16 Million | 82.79 Million |
| Cost of Revenue | 116.62 Million | 73.92 Million | 60.85 Million | 81.37 Million | 50.2 Million | 47.71 Million |
| Gross Profit | 91.35 Million | 58.33 Million | 35.89 Million | 59.52 Million | 30.95 Million | 35.07 Million |
| Operating Expenses | 334.74 Million | 211.56 Million | 155.6 Million | 277.8 Million | 193.88 Million | 127.5 Million |
| Selling, General and Administrative Expenses | - | 144.52 Million | 85.4 Million | - | 112.49 Million | 73.94 Million |
| Research and Development Expenses | - | 67.03 Million | 70 Million | - | 81.38 Million | 53.55 Million |
| Other Expenses | 1.72 Million | - | -186.6 Thousand | 2.23 Million | - | - |
| Cost and Expenses | 451.36 Million | 285.49 Million | 216.45 Million | 359.17 Million | 244.09 Million | 175.21 Million |
| Operating Income | -193.7 Million | -153.23 Million | -119.7 Million | -126.11 Million | -162.92 Million | -92.42 Million |
| Interest Expense | 6.81 Million | 5.52 Million | 1.91 Million | 3.1 Million | 1.86 Million | 1.74 Million |
| Income Tax Expense | -2.97 Million | -7.78 Million | 4.79 Million | 6.01 Million | 5.04 Million | 1.82 Million |
| Earnings before Tax | -196.31 Million | -149.15 Million | -65.88 Million | -126.61 Million | -106.12 Million | -38.68 Million |
| Net Income | -191.68 Million | -140.78 Million | -69.4 Million | -123.16 Million | -110.62 Million | -40.07 Million |
| Earnings Per Share Basic | - | -0.51 | -0.25 | - | -0.40 | -0.15 |
| Earnings Per Share Diluted | - | -0.51 | -0.25 | - | -0.40 | -0.15 |
| Weighted Average Shares Outstanding | 273.52 Million | 273.52 Million | 273.52 Million | 273.52 Million | 273.52 Million | 273.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 273.52 Million | 273.52 Million | 273.52 Million | 273.52 Million | 273.52 Million | 273.52 Million |
| Gross Margin | 0.44 | 0.44 | 0.37 | 0.42 | 0.38 | 0.42 |
| EBIT Margin | - | -1.05 | -1.17 | - | -1.95 | -1.06 |
| Profit Margin | -0.92 | -1.06 | -0.72 | -0.87 | -1.36 | -0.48 |
| EBITDA | - | -138.3 Million | -113.19 Million | - | -158.64 Million | -87.96 Million |
| Earnings Before Tax Margin | -0.93 | -1.16 | -1.24 | -0.90 | -2.01 | -1.12 |
CYB
SYNT
300033
YGTYF
301183
LEDIBOND